IBEX Limited financials
$43.38−2.14%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '26 Jun 30 | Q3 '26 Mar 31 | Q2 '26 Dec 31 | Q1 '26 Sep 30 | Q4 '25 Jun 30 | Q3 '25 Mar 31 | Q2 '25 Dec 31 | Q1 '25 Sep 30 | Q4 '24 Jun 30 | Q3 '24 Mar 31 | Q2 '24 Dec 31 | Q1 '24 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $164.3M | $164.4M | $164.2M | $151.2M | $147.1M | $140.7M | $140.7M | $129.7M | $124.5M | $126.8M | $132.6M | $124.6M |
| Gross profit | $46.9M | $48.8M | $47.6M | $44.6M | $46.3M | $44.7M | $41.9M | $39.7M | $39.2M | $39.7M | $36.8M | $36.4M |
| Gross margin | 28.6% | 29.7% | 29.0% | 29.5% | 31.4% | 31.8% | 29.8% | 30.6% | 31.4% | 31.3% | 27.7% | 29.2% |
| Operating income | $9.8M | $16.2M | $15.3M | $13.7M | $12.3M | $13.3M | $11.9M | $9.1M | $12.9M | $11.3M | $6.9M | $8.3M |
| Net income | $8.7M | $13.3M | $12.2M | $12.0M | $9.6M | $10.5M | $9.3M | $7.5M | $9.8M | $10.3M | $6.1M | $7.4M |
| Net margin | 5.3% | 8.1% | 7.4% | 8.0% | 6.5% | 7.4% | 6.6% | 5.8% | 7.9% | 8.1% | 4.6% | 6.0% |
| Diluted EPS | $0.59 | $0.89 | $0.83 | $0.82 | $0.66 | $0.73 | $0.57 | $0.43 | $0.56 | $0.57 | $0.33 | $0.39 |
| EBITDA | $15.4M | $21.3M | $20.0M | $18.1M | $16.5M | $17.7M | $16.2M | $13.5M | $12.9M | $16.1M | $11.9M | $13.4M |
| Operating cash flow | $24.8M | $11.9M | $6.6M | $15.7M | $27.9M | $8.8M | $1.1M | $7.8M | $17.4M | $11.4M | -$1.6M | $8.7M |
| Free cash flow | $21.7M | $6.6M | -$5.1M | $8.0M | $22.8M | $3.6M | -$3.2M | $4.1M | $15.2M | $9.7M | -$4.5M | $6.6M |
| Diluted shares | 14.9M | 15.0M | 14.7M | 14.6M | 14.6M | 14.4M | 16.5M | 17.5M | 17.6M | 18.0M | 18.4M | 18.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $32.6M | $15.4M | $15.5M | $22.7M | $15.3M | $13.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.7M | $1.4M | $1.4M | $1.6M | $1.6M | $20.6M |
| Total assets | $309.1M | $297.2M | $295.8M | $283.9M | $273.2M | $274.7M |
| Total liabilities | $138.9M | $136.5M | $141.3M | $140.2M | $138.9M | $150.6M |
| Shareholders' equity | $170.2M | $160.8M | $154.5M | $143.6M | $134.3M | $124.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology